The gamma interferon (IFN-γ) mimetic peptide IFN-γ(95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice

Clinical and Vaccine Immunology

Volumn 13, Issue 8, 2006, Pages 944-952

  Mujtaba, Mustafa G ^a,b   Patel, Chintak B ^a   Patel, Ravi A ^a   Flowers, Lawrence O ^a   Burkhart, Marjorie A ^a   Waiboci, Lilian W ^a   Martin, James ^a   Haider, Mohammad I ^a   Ahmed, Chulbul M ^a   Johnson, Howard M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b FLORIDA GULF COAST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON(95-133); UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOSE RESPONSE; ENCEPHALOMYOCARDITIS VIRUS; HEART; IN VITRO STUDY; IN VIVO STUDY; LETHAL DOSE; LETHALITY; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; SIMIAN VIRUS 40; TISSUE CULTURE; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CARDIOVIRUS INFECTIONS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYOCARDITIS VIRUS; INTERFERON TYPE II; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; PLAQUE ASSAY;

EID: 33748789628     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00021-06     Document Type: Article

References (25)

1. Ahmed, C. M., M. Burkhart, P. S. Subramaniam, M. G. Mujtaba, and H. M. Johnson. 2005. Peptide mimetics of gamma interferon possess antiviral activities against vaccinia and other viruses in the presence of poxvirus B8R protein. J. Virol. 79:5632-5639.
2. Ahmed, C. M. I., M. A. Burkhart, M. G. Mujtaba, P. S. Subramaniam, and H. M. Johnson. 2003. The role of IFN-γ nuclear localization sequence in intracellular function. J. Cell Sci. 116:3089-3098.
3. Alcami, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
4. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
5. Brewer, L., C. Brown, M. P. Murtaugh, and M. Njenga. 2003. Transmission of porcine encephalomyocarditis virus (EMCV) to mice by transplanting EMCV-infected pig tissues. Xenotransplantation 10:569-576.
6. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147:258-267.
7. Johnson, H. M. 1985. Mechanism of gamma interferon production and assessment of immunoregulatory properties, p. 33-45. In E. Pick and M. Landy (ed.), Lymphokines, vol. 11. Academic Press, Orlando, Fla.
8. Katze, M. G., Y. He, and M. Gale. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
9. Kirkland, P. D., A. B. Gleeson, R. A. Hawkes, H. M. Naim, and C. R. Broughton. 1989. Human infection with encephalomyocarditis virus in New South Wales. Med. J. Aust. 151:176-177.
10. Kruppenbacher, J. P., T. Viertens, H. Muntefering, and H. J. Eggers. 1985. Encephalomyocarditis virus and diabetes mellitus: studies on virus mutants in susceptible and non-susceptible mice. J. Gen. Virol. 66:727-732.
11. LaRue, R., S. Myers, L. Brewer, D. P. Shaw, C. Brown, B. Seal, and M. Njenga. 2003. A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques. J. Virol. 77:9136-9146.
12. Lodmell, D. L., and L. C. Ewalt. 1978. Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. Infect. Immun. 19:225-230.
13. Moss, B., and J. L. Shisler. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:59-66.
14. Schellekens, H., G. Geelen, J. F. Meritet, C. Maury, and M. G. Tovey. 2001. Oromucosal interferon therapy: relationship between antiviral activity and viral load. J. Interferon Cytokine Res. 21:575-581.
15. Subramaniam, P. S., B. A. Torres, and H. M. Johnson. 2001. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine 15:175-187.
16. Subramaniam, P. S., J. Larkin, M. G. Mujtaba, M. R. Walter, and H. M. Johnson. 2000. The COOH terminal nuclear localization sequence of interferon-γ regulates STAT1α nuclear translocation at an intracellular site. J. Cell Sci. 113:2771-2781.
17. Subramaniam, P. S., L. O. Flowers, S. I. Haider, and H. M. Johnson. 2004. Signal transduction mechanism of a peptide mimetic of interferon-γ. Biochemistry 43:5445-5454.
18. Subramaniam, P. S., M. G. Mujtaba, M. R. Paddy, and H. M. Johnson. 1999. The C-terminus of interferon-γ contains a functional polybasic nuclear localization sequence. J. Biol. Chem. 274:403-407.
19. Subramaniam, P. S., M. M. Green, J. Larkin, B. A. Torres, and H. M. Johnson. 2001. Nuclear translocation of IFN-γ is an intrinsic requirement for its biological activity and can be driven by a heterologous nuclear localization sequence. J. Interferon Cytokine Res. 21:951-959.
20. Symons, J. A., D. C. Tscharke, N. Price, and G. L. Smith. 2002. A study of the vaccinia virus interferon gamma receptor and its contribution to virus virulence. J. Gen. Virol. 83:1953-1964.
21. Szente, B. E., J. M. Soos, and H. M. Johnson. 1994. The C-terminus of IFN gamma is sufficient for intracellular function. Biochem. Biophys. Res. Commun. 203:1645-1654.
22. Szente, B. E., P. S. Subramaniam, and H. M. Johnson. 1995. Identification of IFN-gamma receptor binding sites for JAK2 and enhancement of binding by IFN-gamma and its C-terminal peptide IFN-γ(95-133). J. Immunol. 155:5617-5622.
23. Thiam, K., E. Loing, C. Verwaerde, C. Auriault, and H. Gras-Masse. 1999. IFN-γ-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. J. Med. Chem. 42:3732-3736.
24. Thiam, K., E. Loing, A. Delanoye, E. Diesis, H. Gras-Masse, C. Auriault, and C. Verwaerde. 1998. Unrestricted agonist activity on murine and human cells of lipopeptide derived from IFN-gamma. Biochem. Biophys. Res. Commun. 253:639-647.
25. Wells, S. K., and A. E. Gutter. 1989. Encephalomyocarditis virus: epizootic in a zoological collection. J. Zoo Wildl. Med. 20:291-296.